(33 days)
No
The device description focuses on mechanical and electronic controls for applying distraction forces, with no mention of adaptive learning, pattern recognition, or data-driven decision-making characteristic of AI/ML. The control panel is described as being programmed for static or intermittent distraction, which implies pre-set parameters rather than intelligent adaptation.
Yes
The device is intended to provide "relief from pain" and "relieve pressures on structures that may be causing low back pain," as well as "relieve pain associated with herniated discs, protruding discs, degenerative disc disease, posterior facet syndrome, and sciatica." These stated intended uses clearly describe a therapeutic purpose.
No
The device description indicates that the DRS System provides treatments for pain relief by applying distraction forces to the lumbar spine. It does not mention any diagnostic capabilities, such as identifying conditions or providing diagnostic information.
No
The device description clearly outlines multiple hardware components including a bed, harnesses, a distraction unit, a control panel, and safety switches. While there is a "programmed and control panel," the primary function and description focus on the mechanical and physical aspects of the device.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In Vitro Diagnostic devices are used to examine specimens taken from the human body (like blood, urine, or tissue) to provide information for diagnosis, monitoring, or screening.
- DRS System Function: The DRS System is a physical therapy device that applies mechanical forces (distraction) to the patient's lumbar spine to relieve pain. It does not analyze any biological samples.
- Intended Use: The intended use clearly states it's for "relief from pain for those patients suffering with low back pain" through mechanical decompression.
- Device Description: The description details a mechanical bed and traction system, not equipment for analyzing biological specimens.
Therefore, the DRS System falls under the category of a therapeutic medical device, not an In Vitro Diagnostic device.
N/A
Intended Use / Indications for Use
The DRS System provides a program of treatments for relief from pain for those patients suffering with low back pain. Each treatment consists of a physician prescribed treatment period on the DRS System and is designed to provide static, intermittent, and cycling distraction forces to relieve pressures on structures that may be causing low back pain. It relieves pain associated with hemiated discs, protruding discs, degenerative disc disease, posterior facet syndrome, and sciatica. It achieves these effects through decompression of intervertebral discs, that is, unloading due to distraction and positioning.
Product codes
89ITH
Device Description
The DRS System™ is designed to apply distraction forces to a patient's lumbar spine.
The key elements are as follows:
-
- The bed is a stand on/stand off tilt type bed that allows the fully clothed patient to position. The bed and patient can then be slowly lowered to the horizontal treatment position using a remote controller hand held by the practitioner.
- Once in the horizontal position the bed can be raised or lowered to the practitioner's preferred treatment height via the same hand held remote controller.
-
- The bed is split into two cushions, each slideable in the horizontal plane only on low friction runners and each being able to be locked independently.
- Distraction tensions are applied to the patient via a pelvic harness while the upper body of the patient is anchored to the locked upper (cephalic) cushion via a chest harness and adjustable underarm supports. The lower cushion, which is unlocked and on which the patient's lower trunk is rested, is able to slide easily thus reducing almost completely any frictional movement between patient and bed cushion when distraction tensions are applied, this concentrates virtually all the forces to the affected part of the lumbar spine.
- The distraction unit (Vertrac) is mounted to a vertical movable platform incorporated into a support tower (Omni Tower) at the foot end of the bed. This enables the distraction tensions to be applied at differing angles to the patient (between 0 and 30 degrees).
-
- The "Vertrac" unit is programmed and control panel fitted into the "Omni Tower" to give static or intermittent distraction.
-
- The minimum and maximum distraction settings are 0-200 lbs ..
-
- Treatment parameters i.e. tensions and time are continuously monitored and shown by LCD readout at the time of treatment set up and during treatment.
- At the conclusion of treatment time, tension always returns to zero.
-
- A cassette player, which is incorporated in a separate section of the control panel, and wireless headphones together with an overhead fluorescent "black light" provide comfort and relaxation to the patient.
-
- There is instantaneous release of all tensions if the patient pushes the button on the hand held Patient Safety Switch, or the Stop Button on the control panel has been pushed by the practitioner.
-
- The DRS System™ will not operate if the Patient Safety Switch is not working properly or has not been tested prior to each treatment.
-
- The treatment cannot be restarted when a patient activates the Patient Safety Switch or the Stop Button has been pushed during treatment unless all treatment parameters are manually re-entered into the controller.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
lumbar spine
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Clinical trials carried out by VAX-D endorse the principle of decompression, however, enclosed are extracts from study papers carried out using The DRS System, which further confirms same.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
K844385 Tru-Trac 401 Traction - Henley International, K951622 VAX-D® Therapeutic Table - Vat-Tech, Inc.
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 890.5900 Power traction equipment.
(a)
Identification. Powered traction equipment consists of powered devices intended for medical purposes for use in conjunction with traction accessories, such as belts and harnesses, to exert therapeutic pulling forces on the patient's body.(b)
Classification. Class II (performance standards).
0
Image /page/0/Picture/2 description: The image shows a date, "JUN 24 1998". The month is June, the day is the 24th, and the year is 1998. The text is in a bold, sans-serif font. The text is black on a white background.
Image /page/0/Picture/3 description: The image shows the logo for PDS, Professional Distribution Systems, Inc. The letters PDS are in a large, bold, sans-serif font. Underneath each letter are three horizontal lines. The words "PROFESSIONAL DISTRIBUTION SYSTEMS, INC." are in a smaller font below the letters.
company, trading symbol CLIT. PDS Inc. is a wholly owned subsidiary of Cluster Technology, Corp., a public
SECTION VII
510(k) SUMMARY OF SAFETY AND EFFECTIVENESS
[As required by 21 CFR 807.92]
Name of Manufacturer
Professional Distribution Systems, Inc. 1160 South Rogers Circle, Bldg. A Boca Raton, FL 33487 Tel: (561) 988-1747 / Fax: (561) 988-0967
David Williams, President & CEO Professional Distribution Systems, Inc. Tel: (561) 988-1747 / Fax (561) 988-9067
Date of Summary Preparation
May 21, 1998
Device Description
Contact Person:
Device Proprietary Name: Common Name: Classification Name: Class and Reference Product Code: Panel Code:
DRS System Traction Equipment Power Traction Equipment Class II (21 CFR Section 890.5900) 89ITH 87ORS
Predicate Devices:
K844385 Tru-Trac 401 Traction - Henley International K951622 VAX-D® Therapeutic Table - Vat-Tech, Inc.
Device Description
The DRS System™ is designed to apply distraction forces to a patient's lumbar spine.
The key elements are as follows:
- The bed is a stand on/stand off tilt type bed that allows the fully clothed patient to 1. The bed is a stails on stail on the rype ood position. The bed and patient can then
Section VII, Page 1 of 5, Rev. A
1160 South Rogers Circle . Bldg. A . Boca Raton, Florida 33487 . 561-988-1747 . Fax 561-988-1749
1
Professional Distribution Systems, Inc. DRS System™ - 510(k) Notification
SUMMARY OF SAFETY AND EFFECTIVENESS
be slowly lowered to the horizontal treatment position using a remote controller hand held by the practitioner.
- Once in the horizontal position the bed can be raised or lowered to the practitioner's ﻨ preferred treatment height via the same hand held remote controller.
- The bed is split into two cushions, each slideable in the horizontal plane only on low 3. friction runners and each being able to be locked independently.
- Distraction tensions are applied to the patient via a pelvic harness while the upper ধ body of the patient is anchored to the locked upper (cephalic) cushion via a chest harness and adjustable underarm supports. The lower cushion, which is unlocked and on which the patient's lower trunk is rested, is able to slide easily thus reducing almost completely any frictional movement between patient and bed cushion when distraction tensions are applied, this concentrates virtually all the forces to the affected part of the lumbar spine.
- The distraction unit (Vertrac) is mounted to a vertical movable platform incorporated র্বা into a support tower (Omni Tower) at the foot end of the bed. This enables the distraction tensions to be applied at differing angles to the patient (between 0 and 30 degrees).
-
- The "Vertrac" unit is programmed and control panel fitted into the "Omni Tower" to give static or intermittent distraction.
-
- The minimum and maximum distraction settings are 0-200 lbs ..
-
- Treatment parameters i.e. tensions and time are continuously monitored and shown by LCD readout at the time of treatment set up and during treatment.
- At the conclusion of treatment time, tension always returns to zero. ರ್.
-
- A cassette player, which is incorporated in a separate section of the control panel, and wireless headphones together with an overhead fluorescent "black light" provide comfort and relaxation to the patient.
-
- There is instantaneous release of all tensions if the patient pushes the button on the hand held Patient Safety Switch, or the Stop Button on the control panel has been pushed by the practitioner.
-
- The DRS System™ will not operate if the Patient Safety Switch is not working properly or has not been tested prior to each treatment.
-
- The treatment cannot be restarted when a patient activates the Patient Safety Switch or the Stop Button has been pushed during treatment unless all treatment parameters are manually re-entered into the controller.
Intended Use
The DRS System™ provides a program of treatments for relief from pain for those patients suffering with low back pain. Each treatment consists of a physician prescribed treatment period on the DRS System and is designed to provide static, intermittent, and cycling distraction forces to relieve pressures on structures that may be causing low back pain. It relieves pain associated with hemiated discs, protruding discs, degenerative disc disease, posterior facet syndrome, and sciatica. It achieves these effects through
2
Professional Distribution Systems, Inc. DRS System™ - 510(k) Notification
SUMMARY OF SAFETY AND EFFECTIVENESS
decompression of intervertebral discs, that is, unloading due to distraction and positioning.
Technological Characteristics
The DRS System™ incorporates various principles and working characteristics of the predicate devices, Tru-Trac 401 Traction Device (K844385) and the VAX-D Therapeutic Table (K951622). The incorporating of the traction device and a flat surface type powered bed, whilst giving a new overall appearance to the apparatus, has not impacted on or changed the safety of effectiveness of the devices.
Clinical trials carried out by VAX-D endorse the principle of decompression, however, enclosed are extracts from study papers carried out using The DRS System 14, which further confirms same. (See Bibliography on Page 5 of this Section.)
We will further confirm that this summary contains only information that is within the main body of the 510(k), and no unsubstantiated labeling, claims, raw data, trade secrets, or patient identification information.
Summary of Safety and Effectiveness
The principles of operation the DRS System™ are such that it permits the usefulness of effective distraction tensions to the lumbar spine. The more important safety features include:
-
- The activation of pillars and actuators for the bed are via a 24-volt electrical circuit.
- The control circuitry for the distraction unit including the power supply to the Patient 2. Safety Switch is a maximum 24 volts.
- నా The patient is automatically reclined to the treatment position rather than climbing onto the treatment bed.
-
- Adjustable handgrips are fitted for the patient to hold while the bed is being slowly reclined.
-
- There is instantaneous release of all tensions when the button on the hand held Patient Safety Switch is depressed, the Stop Button is pressed on the control panel, or when electrical current is interrupted. The treatment program cannot be automatically restarted when any of those items in no. "5" have occurred without the full treatment parameters being manually re-entered into the control panel.
- All treatment parameters must be manually entered each time a treatment occurs. 6.
-
- There is a limited vertical movement of the traction box.
- There is a permanent, visible means of indication of the angle of distraction pull. రం
- There is an audible warning signal when the unit is first turned on, when the treatment の is completed, when the Patient Safety Switch is tested, when the Patient Safety Switch is activated during treatment, and when the entered treatment distraction parameter exceeds 39 lbs. force of tension.
3
PAGE 09
SUMMARY OF SAFETY AND EFFECTIVENESS
The Tru-Trac 401 has been in use in this country for more than ten years and we have no evidence of a MDR report being filed by the manufacturer nor have we been made aware of any events or conditions effecting the operation of this equipment during all trials carried out by PDS.
4
June 17, 1998
Professional Distribution Systems, Inc. DRS System™ - 510(k) Notification
SUMMARY OF SAFETY AND EFFECTIVENESS
Bibliography of Extracts from Study Papers Carried Out Using the DRS SYSTEM.
-
- Shealy, C. Norman, and Borgmeyer, Vera (1997) Decompression, Reduction, and Stabilization of the Lumbar Spine: A Cost Effective Treatment for Lumbosacral Pain. American Journal of Pain Management, Vol. 7, p. 63-65.
-
- Shealy, C. Norman, and LeRoy, Pierre L. (1998) New Concepts in Back Pain Management: Decompression, Reduction, and Stabilization. St. Lucie Press, Boca Raton, FL. Chapter 20, p. 239-257.
5
Image /page/5/Picture/2 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of the department's name arranged in a circular fashion around the perimeter. To the right of the text is a symbol featuring a stylized human figure in profile, composed of three overlapping silhouettes.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
JUN 24 1998
Mr. David Williams · President & CEO Professional Distribution Systems, Inc. 1160 South Rogers Circle, Building A Boca Raton, Florida 33487
K981822 Re: DRS System Trade Name: Requlatory Class: II Product Code: ITH May 21, 1998 Dated: Received: May 22, 1998
Dear Mr. Williams:
We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions The general controls provisions of the Act of the Act. include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Requlations, Title 21, Parts 800 to 895. ਸੇ substantially equivalent determination assumes compliance with the current Good Manufacturing Practice requirement, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic (QS) inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory In addition, FDA may publish further announcements action. Please note: concerning your device in the Federal Register. this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations.
6
Page 2 - Mr. David Williams
This letter will allow you to begin marketing your device as This letter will allow you co begin motification. The FDA described in your 510(K) prematice of your device to a legally
finding of substantial equivalence of classification for vour finding of substancial equivatine of jolassification for your marketed predicate device resures in a classes.
device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling If you desire specific advice for gitionally 809.10 for in regulacion (21 cm rate over are contact the Office of
vitro diagnostic devices), please contact the for questio vitro diagnostic devices), predoc otionally, for questions on
Compliance at (301) 594–4659. Additionalize plaase contact Compliance at (301) 334 4037. India device, please contact
the promotion and advertising of your accommon the promotion and advertising or jour 4639. Also, please note the Office Of Compriand, "Misbranding by reference to the regulation entitled, "Misblanding my Dother general premation on your responsibilities under the Act may be information on your responsiblish of Small Manufacturers Assistance obtained from the Division or (301) 638-2041 or (301) 443-6597 or at at its coll-iree number (000)- 050-2007-05-28 11:51".
its internet address "http://www.fda.gov/cdrh/dsmamain.html".
Sincerely yours,
J. Cole
Celia M. Witten, Ph.D., M.D. Director Division of General and Restorative Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
7
June 17, 1998
Professional Distribution Systems, Inc. DRS System™ - 510(k) Notification
510(k) Number (if known): K981822
Device Name: DRS System
Indications For Use:
Intended Use
The DRS System provides a program of treatments for relief from pain for those patients suffering with low back pain. Each treatment consists of a physician prescribed treatment period on the DRS System and is designed to provide static, intermittent, and cycling distraction forces to relieve pressures on structures that may be causing low back pain. It relieves pain associated with herniated discs, protruding discs, degenerative disc discase, posterior facer syndrome, and sciatica. It achieves these effects through decompression of intervertebral discs, that is, unloading due to distraction and positioning.
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
(Division Sign-Off)
Division of General Restorative Devices
510(k) Number be C981822
X Prescription Use (Per 21 CFR 801.109)
OR
Over-The-Counter Use